Novo Nordisk’s Earnings Surge on Frenzy for Obesity Drugs
Novo Nordisk A/S sales surged in the third quarter as demand continued unabated for its obesity and diabetes
1970-01-01 08:00
Novo Nordisk flags continued restrictions on Wegovy supplies
COPENHAGEN (Reuters) -Novo Nordisk on Thursday reported record sales and operating profits for the third quarter but flagged continued restrictions
1970-01-01 08:00
When Japan Ends Negative Rate Policy, Treasuries Will Suffer
Japan’s era of negative interest rates will end in coming months, and the implications for world markets will
1970-01-01 08:00
China Weight-Loss Drug Stocks Lose Shine on ‘Misleading’ Claims
One of the few bright spots in China’s battered equity market is evaporating, with weight-loss drugs plunging after
1970-01-01 08:00
Novo Nordisk in $1.3 billion deal to buy hypertension drug
COPENHAGEN Novo Nordisk has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in cardiovascular
1970-01-01 08:00
A $245 Billion Selloff Signals Less Sparkly Future for Luxury Stocks
The wealthy shoppers who fueled LVMH’s rise to Europe’s most valuable company and made its founder the world’s
1970-01-01 08:00
Novo’s Blockbuster Ozempic Now Shows Kidney Promise, Hitting Rivals
Novo Nordisk A/S said a kidney failure study of its diabetes drug Ozempic showed effectiveness surprisingly early, sending
1970-01-01 08:00
LVMH Sales Growth Slows as Global Luxury Demand Cools
LVMH’s sales growth softened in the third quarter as shoppers reined in spending on high-end Cognac and costly
1970-01-01 08:00
Novo Nordisk's Wegovy bonanza looms large in Denmark
By Maggie Fick COPENHAGEN The whirlwind success of weight-loss treatment Wegovy is providing a bonanza not just for
1970-01-01 08:00
Ozempic Is Causing ‘Slight Pullback’ by Shoppers, Walmart Says
Walmart Inc. says it’s already seeing an impact on shopping demand from people taking the diabetes drug Ozempic,
1970-01-01 08:00
If Ozempic Makes People Eat Less, Maker of Cheez-It Will Be Ready
Diabetes drug Ozempic and other appetite-suppressing medications are set to help overweight Americans cut down on their calorie
1970-01-01 08:00
Weight-Loss Drugmaker Carmot Therapeutics Is Considering IPO
Weight-loss drugmaker Carmot Therapeutics is exploring an initial public offering, according to people with knowledge of the matter.
1970-01-01 08:00